Researchers have found an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of inflammatory bowel disease (IBD) called Crohn’s disease.
Researchers have found an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of inflammatory bowel disease (IBD) called Crohn’s disease.